CriteriaGastroenterology and hepatology
Revised autoimmune hepatitis score (IAIHG 1999)
International Autoimmune Hepatitis Group point system that classifies the diagnosis as definite or probable, before or after treatment.
Updated 31 October 2026
When to use it
Doubtful or atypical cases of autoimmune hepatitis, overlap syndromes and clinical studies; requires a liver biopsy.
What it needs
- Sex
- Alkaline phosphatase
- Alkaline phosphatase upper limit of normal
- AST or ALT
- Upper limit of normal of that aminotransferase
- Globulins, γ-globulins or IgG (times the upper limit of normal)
- ANA, SMA or anti-LKM-1 (adult titre)
- Antimitochondrial antibodies (AMA) positive
- Viral hepatitis markers (IgM anti-HAV, HBsAg, IgM anti-HBc, anti-HCV, HCV RNA)
- Recent or current use of hepatotoxic drugs
- Average alcohol intake
- Other autoimmune disease in the patient or first-degree relatives
- Other defined autoantibodies (p-ANCA, anti-SLA/LP, anti-LC1, anti-ASGPR)
- HLA DR3 or DR4
- Interface hepatitis
- Predominantly lymphoplasmacytic infiltrate
- Rosetting of liver cells
- Biliary changes
- Other changes suggesting a different aetiology
- Has immunosuppressive treatment been given?
- Response to treatment
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ 9 | < 10: autoimmune hepatitis unlikely |
| 10–15 | 10–15: probable autoimmune hepatitis |
| ≥ 16 | > 15: definite autoimmune hepatitis |
In the app it also calculates: Post-treatment score.
Practical tip
In daily practice the 2008 simplified criteria (4 variables) are easier; the revised score is more sensitive in atypical cases.
3 more practical tips in the app.
Reference
- Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929-938.
- Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169-176.
- Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis. 2004;1(1):2.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
